Abstract
Abstract This paper compares the uptake of prenatal screening for fetal abnormality with that of the recently introduced test for carriers of cystic fibrosis. While the former is widely accepted, the latter appears to be of much less interest to the relevant population. It is argued that prenatal screening is seen as a part of an antenatal care 'package'. Knowledge about the tests and their implications is limited except for those women who know themselves to be at particular risk. Most of the remainder seek reassurance that all is well through antenatal care and the prenatal screening that makes up part of the package. It is argued that interest in carrier detection for genetic diseases like cystic fibrosis is limited because mast people who have not had direct contact with the disease do not see themselves to be at risk. One reason for this is that they may hold beliefs about inheritance which indicate that they cannot be a carrier if they do not have a close relative with the disease. It is suggested t...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.